Advanced Chemistry

Patrick Da Costa has completed his PhD at the age of 27 years from University Pierre et Marie Curie and postdoctoral studies from UC Berkekey. He is now Full Professor at Sorbonne University, in Faculty of Science and Engineering. He has published more than 150 papers in reputed journals and has been serving as an editorial board member of different journals in Chemistry and Chemical Engineering

Environmental Chemistry

Dr Laurent Désaubry is a CNRS research director in the University of Strasbourg in France (website: http://desaubry.u-strasbg.fr/) and adjunct professor at Tianjin University of Science and Technology (TUST) in China. In 1992, he received a Ph.D. degree in medicinal chemistry from Strasbourg University. Next, he worked as a postdoctoral fellow at SUNY at Stony Brook, USA. He made another post-doctoral internship in Prof. Pierre Chambon’s laboratory before to get a CNRS Research Senior Scientist at the University of Strasbourg-CNRS. He was promoted CNRS research director (corresponds to full professor) in 2014, and became also professor at TUST in 2015. He has published more than 70 publications and has been serving as an editorial board member of Frontiers in Chemistry, Medicinal Chemistry, Advances in Oncology Research and Treatments and The Open Medicinal Chemistry Journal.

Medicinal Chemistry

Dr. Wei Li has been working at the College of Pharmacy, the University of Tennessee Health Science Center (UTCoP) since he obtained his PhD in chemistry from Columbia University in 1999. Currently he is a Professor and the Director of the UTCoP Drug Discovery Center. His focus of research is small molecule drug discovery, and currently his research is mainly funded by NIH/NCI grants. He has published over 135 papers, 3 book chapters, five issued US patents, and additional patents from other countries. He is a frequent grant reviewer for NIH study sections, and currently he is an editorial board member for Current Medicinal Chemistry, Molecules, and Acta Pharmaceutica Sinica B.

Pharmaceutical Chemistry

Professor Katarina Nikolic has completed her PhD at the age of 31 years from Faculty of Pharmacy, University of Belgrade. She is the Associate Professor at Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Serbia. The main areas of her research involve: molecular modeling, pharmacophore modeling, virtual screening, molecular docking and molecular dynamic, computer-aided drug design, lead optimisation, synthesis, and chemometry. Her research is currently focused on discovery of novel CNS drugs and antineoplastic agents. Her team has long-lasting research collaboration with several leading European Universities via few Horison2020/COST projects which are focused on rational drug design and discovery.She has published more than 75 papers in reputed journals.

Pharmaceutical Chemistry

Seyed Hamed Mahdaviani received his B.Sc. degree in Chemical Engineering from Amirkabir University of Technology, Tehran and his M.Sc. degree in Chemical Engineering from Iran University of Science and Technology, Tehran, Iran. He has many publications including 15 high quality peer-reviewed papers in scientific journals and international conferences, a book chapter, an Iran patent and several research and technical reports. He received several honors and awards for his outstanding efforts in his research works. In December 2015, he was selected as the first person of superior industrialist and distinguished researcher in the Festival of Research & Technology of Oil Industry in Tehran, Iran. He has been invited to the several reputed international conferences as a keynote speaker. He has received certificate of reviewing from Elsevier in recognition of the review made for Applied Catalysis A: General in March 2016.

Petro Chemicals

Dr. John Hu, an experienced scientist and engineer, is a Chair Professor and the Director of Center for Innovation in Gas Research and Utilization at West Virginia University. As a director, John leads the creation of an interdisciplinary research center related to natural gas utilization, which is a strategic area of investment for WVU. John worked as a Director of Technology Innovation at Koch Industries, where he was responsible for developing future technological growth areas related to petrochemicals and catalytic and biological processing. John worked as a research manager at Pacific Northwest National Laboratory, undertaking DOE, DOD, and NASA projects. In the late 1990s, he served as a lead refinery engineer for BP Oil. John has been granted 25 U.S. patents and published more than 90 peer reviewed journal and conference papers.

Petro Chemicals